Over $300 million has been invested in listeria platform to date, mostly by Advaxis/Ayala (OS acquired all listeria-based assets in April 2025) OST-HER2: Listeria monocytogenes (Lm): ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results